by Jordana Choucair | Nov 30, 2022 | Opioid/Substance Use Disorders
New data published Wednesday by the National Center for Health Statistics show that deaths from drug and alcohol use are rising among America’s seniors. According to the data, drug overdose deaths more than tripled among people aged 65 and older during the past two...
by Jordana Choucair | Nov 29, 2022 | Opioid/Substance Use Disorders
The Department of Health and Human Services (HHS) proposed a rule to align 42 CFR Part 2 privacy protections with HIPAA. The rule would require one-time patient consent for disclosure of treatment and allowing HIPAA-covered entities to access those records. The rule...
by Jordana Choucair | Nov 22, 2022 | Opioid/Substance Use Disorders
A Kaiser Health News (KHN) article examines how states are planning to spend the $26 billion for the opioid settlement fund. The settlement includes specific parameters for how the states can spend the money: 70 percent must be used for opioid-related expenses (e.g.,...
by Jordana Choucair | Nov 18, 2022 | Opioid/Substance Use Disorders
A study published in JAMA Network Open found that individuals with substance use disorders (SUDs) had significant annual declines in SUD-related emergency department use over five years compared with patients who received “usual care.” The study notes that...
by Jordana Choucair | Nov 16, 2022 | Opioid/Substance Use Disorders
The opioid overdose reversal drug naloxone may be safe and effective for over-the-counter use in some forms, the U.S. Food and Drug Administration (FDA) said on Tuesday. The FDA would still require data on individual products from manufacturers for them to be...
by Jordana Choucair | Nov 15, 2022 | Opioid/Substance Use Disorders
Walmart Inc. has agreed to pay $3.1 billion to settle lawsuits brought by states, cities, and Native American tribes over its role in the opioid crisis. However, the company did not admit liability. Walmart’s agreement follows settlements earlier this month from...
Recent Comments